We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
43 hedge funds and large institutions have $21M invested in CTI BioPharma Corp. (DE) Common Stock in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
10% less capital invested
Capital invested by funds: $23.4M → $21M (-$2.4M)
25% less funds holding
Funds holding: 57 → 43 (-14)
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
88% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 16
Holders
43
Holders Change
-14
Holders Change %
-24.56%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
14
Closed
16
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
-$74K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$215K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$214K |
| 3 |
Squarepoint
New York
|
+$40.3K |
| 4 |
D.E. Shaw & Co
New York
|
+$7.71K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$7.48K |
Top Sellers
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$390K |
| 2 |
Millennium Management
New York
|
-$360K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$331K |
| 4 |
Goldman Sachs
New York
|
-$326K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$161K |
